Skip to content

SANZUMED

Active Private limited companyfounded 2019active for 7 yearsErnest Solvaystraat 30, 1050 IxellesKBO/BCE: BE 0719.918.162

Lifetime

7 annual accounts with figures on one time axis
peak of €123,487 in 2023
€120,515▲ 9.4%
peak of €81,054 in 2025
€81,054▲ 14.0%
peak of €273,098 in 2024
€234,152▼ 14.3%
€43,760▼ 16.5%
Board1 name since 2019
1 director
Documentsfilings and deeds
29-07-20262 days before the deadline
2025micro format
Dividend €120,000Equity from €273,098 to €234,152Debts from €52,406 to €43,760Cash from €65,538 to €42,159

Key points

from the 2025 annual accounts

Equity

€234,152 ▼ 14.3%
273,0982024+81,054Profit-120,000Dividend234,1522025

SANZUMED paid out €120,000 in dividends. That is 148% of the 2025 profit.

Turnover

≈ €300,000 estimated

The micro format states no turnover.

Filings

7 annual accounts 3 late
AprilJune31 JulyOctober202020222024

The 2020 accounts came in latest, 331 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as SANZUMED has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for SANZUMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • 100 sharesdeed of 08-02-2019
Board & ownership

Recent changes

Registered office moved to Ixelles The registered office moved to rue Ernest Solvay 30 (rez-de-chaussée), 1050 Ixelles · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 13-04-2023 · Gazette deed
3 establishments registered Molenbeek-Saint-Jean and Ixelles
Incorporation Founding capital of €18,600, 100 shares, €12,400 paid up · Founded by · appointed as mandate holder · published on 08-02-2019 · Gazette deed
All 14 events

Official details

Source: KBO
Status
Active since 06-02-2019Normal situation
Activity
General medical practiceNACE 862101 activities on the establishment unitsFrom the articles, 5 activities
Establishment units
2.284.932.2951080 Molenbeek-Saint-Jean, since 07-02-2019
2.330.371.2531050 Ixelles, since 07-02-2019and 1 other
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€277,911▼ 14.6%
Filing
Filed on 29-07-2026, 2 days before the end of the filing period
Financials

Insights on SANZUMED

SANZUMED files the micro format. That format states no turnover. The gross margin rose from €45,304 in 2019 to €120,515 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about SANZUMED

What is the company number of SANZUMED?
The company number of SANZUMED is 0719.918.162. The VAT number is the same number with BE in front: BE 0719.918.162.
Where is SANZUMED based?
The registered office is at Ernest Solvaystraat 30, 1050 Ixelles.Company details
What does SANZUMED do?
According to the KBO register, the main activity of the first establishment unit is general medical practice (NACE 86210).
What is the legal form of SANZUMED?
SANZUMED is a private limited company (BV).
When was SANZUMED founded?
SANZUMED was founded on 06-02-2019.
Is SANZUMED still active?
Yes, SANZUMED is an active enterprise in the KBO register.
What is the turnover of SANZUMED?
The turnover in financial year 2025 is about €300,000. This figure is estimated from the gross margin of €120,515 and 2,452 comparable companies of the same size. It probably lies between €200,000 and €460,000. It is a rough estimate.Financials
Is SANZUMED profitable?
In financial year 2025, SANZUMED made a profit of €81,054.
Where can I find the annual accounts of SANZUMED?
SANZUMED filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of SANZUMED due?
SANZUMED must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.